Bracco Targets Cell Therapy Manufacturing with Bead-Free Microbubble Cell Processing
-
By
February 13, 2026
-
3 min
Bracco Imaging is entering the cell therapy manufacturing market with a novel microbubble-based technology intended to replace traditional magnetic beads used for cell selection and activation. This advanced platform utilizes clinically validated lipid-based microbubbles to enhance the efficiency of cell therapy production by streamlining upstream processes and minimizing cellular stress. The zero-footprint nature of the technology simplifies workflows and supports multistep enrichment strategies, potentially expanding applications in immune cell purification. Manufacturing will occur at a new GMP-compliant facility in Geneva, with further performance data expected as early-access partners participate in development.
1. Bracco Imaging introduces a microbubble-based approach for cell therapy. 2. Technology aims to replace magnetic beads for cell selection. 3. Microbubbles reduce cellular stress and simplify workflows. 4. Manufacturing will occur at a GMP-compliant facility in Geneva. 5. Bracco is focused on partnerships for technology development. 6. The platform supports multistep enrichment workflows. 7. Technology will be showcased at Advanced Therapies Week 2026.
Listen Tab content
